"Umoja secures $100m to advance CAR-T cell therapy pipeline" was originally created and published by Pharmaceutical ...

India has reached a milestone in cancer treatment with the first successful allogeneic CAR-T therapy at P. D. Hinduja ...

Australia is home to some truly unique and unexpected creatures, but few are quite as strange and fascinating as the platypus ...

Hinge Bio, Inc., a privately-held biotechnology company, today announced the close of a Series A’ financing led by Point72. Joining Point72 are Ridgeback Capital, InVivium Capital, and Lightswitch ...

UNC Lineberger researchers discovered a three-drug cocktail that enhances the production of T-memory stem cells (TSCMs) in ...

Leerink Partners analyst Thomas Smith has reiterated their bullish stance on KYTX stock, giving a Buy rating on January 13.Stay Ahead of the ...

For patients with relapsed/refractory large B-cell lymphoma, access to lifesaving CD19-directed chimeric antigen receptor (CAR) T-cell therapy may be limited by post-infusion monitoring protocols ...

Colossal Biosciences announced Wednesday it had reached a $10 billion valuation, putting it in rare “unicorn” territory among Texas startups. The Dallas-based genetic engineering startup landed $200 ...

Researchers have discovered a three-drug combination that enhances the generation of CAR-T cells, a type of cancer immunotherapy, and could improve CAR-T cell production for clinical treatments. The ...

The Phase 1 GALLOP study evaluating the investigational CAR-T therapy, CB-010, for treatment of lupus nephritis has launched.

Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings ...

Colossal Biosciences, the world’s first de-extinction company, has today announced $200M in a Series C financing by TWG ...